Tumor heterogeneity and progression: Conceptual foundations for modeling

Invasion and Metastasis

Volumn 16, Issue 4-5, 1996, Pages 177-208

  Greller, Larry D ^a   Tobin, Frank L ^a   Poste, George ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Genetic instability; Growth; Mathematical modeling; Tumor heterogeneity; Tumor progression; Tumorigenesis

Indexed keywords

BLADDER CANCER; CANCER GENETICS; CARCINOGENESIS; CELL HETEROGENEITY; CELL POPULATION; CLONE; HUMAN; HUMAN CELL; MATHEMATICAL MODEL; PHENOMENOLOGY; REVIEW; TISSUE GROWTH; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 0030417280     PISSN: 02511789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (196)

1. Rescigno A, Beck JS: Compartments; in Rosen R (ed): Foundations of Mathematical Biology. New York, Academic Press, 1972, chap 5, pp 255-322.
2. Hart I: Tumor Progression and metastasis (introduction). Cancer Surv 1988;7:551-554.
3. Heppner GH, Miller BE: Tumor heterogeneity: Biological implications and therapeutic consequences. Cancer Metastas Rev 1983;2:5-23.
4. Nowell PC: Mechanisms of tumor progression. Cancer Res 1986;46:2203-2207.
5. Medina D: Tumor Progression; in Becker FF (ed): Cancer - A Comprehensive Treatise, V3 Biology of Tumors. New York, Plenum Press, 1975, pp 99-119.
6. Kerbel RS: Implications of immunological heterogeneity of tumors. Nature 1979;280:358-360.
7. Weber G: Key Enzymes and tumor cell heterogeneity: Antibiot Chemother 1980;28:53-61.
8. Fidler U, Poste G: The heterogeneity of metastatic properties in malignant tumor cells and regulation of the metastatic phenotype; in Owens AH, Coffey DS, Baylin SB (eds): Tumor Cell Heterogeneity: Origins and Implications. New York, Academic Press, 1982, pp 127-145.
9. Jones PA, Chandler LA, Ghazi H, Ahlering T, Dubeau L: DNA Methylation Patterns and Tumor Heterogeneity; in Nicolson GL, Fidler IJ (eds): Tumor Progression and Metastasis. New York, Liss, 1988, pp 173-177.
10. Iannaccone PM: Clone and patch size in chimeric mouse skin. Mathemat Biosci 1980;51:117-123.
11. Cressie N, Hulting FL: A spatial statistical analysis of tumor growth. J Am Stat Assoc 1992;87:272-283.
12. Norton L, Simon R: Tumor size, sensitivity to therapy, and design of treatment schedules. Cancer Treat Rep 1977;61:1307-1317.
13. Siderits RH, Evans CJ, Welling JS: A three-dimensional reconstruction of metastatic adenocarcinoma in lymph node. BioTechniques 1990;8:670-672.
14. Iannaccone PM, Weinberg WC, Deamant FD: On the clonal origin of tumors: A review of experimental models. Int J Cancer 1987;39:778- 784.
15. Parratto NP, Kimura AK: Isolation and visualization of Met-72-positive metastatic variants present in B16 melanoma tumor masses. J Cell Biochem 1988;36:311-322.
16. Nowell PC: The clonal evolution of tumor cell populations. Science 1976;194:23-28.
17. Foulds L: The experimental study of tumor progression: A review. Cancer Res 1954;14:327-339.
18. Foulds L: Neoplastic Development. London, Academic Press, 1969, vol 1.
19. Foulds L: Neoplastic Development. London, Academic Press, 1975, vol 2.
20. Foulds L: The natural history of cancer. J Chron Dis 1958;8:2-37.
21. Nicolson GL, Poste G: Tumor implantation and invasion at metastatic sites. Int Rev Exp Pathol 1983;25:77-181.
22. Poste G: Experimental systems for analysis of the malignant pheno- type. Cancer Metast Rev 1982;1: 141-199.
23. Nicolson GL, Poste G: Tumor cell diversity and host responses in cancer metastasis. 1. Properties of metastatic cells. Curr Probl Cancer 1982;7:1-83.
24. Killion JJ, Fidler IJ: Evasion of host responses in metastasis: Implications of cellular resistance to cytokines. Curr Biol 1990;2:693-696.
25. Eldredge N, Gould SJ: Punctuated equilibria: An alternative to phyletic gradualism; in Schopf TJM (ed): Models in Paleobiology. San Francisco, Freeman, Cooper, 1972, pp 82-115.
26. Eldredge N: Time Frames: The Evolution of Punctuated Equilibria. Princeton, Princeton University Press, 1985.
27. Farber E, Rubin H: Cellular adaption in the origin and development of cancer. Cancer Res 1991;51:2751-2761.
28. Nowell PC: The clonal nature of neoplasia. Cancer Cells 1989;1:29- 30.
29. Eigen M, McCaskill J, Schuster P: Molecular quasi-species. J Phys Chem 1988;92:6881-6891.
30. Eigen M: The origin of genetic information: Viruses as models. Gene 1993;135:37-47.
31. Nowak MA: What is a quasispecies? Trends Ecol Evol 1992;7:118-121.
32. Karlin S: 11th R.A. Fisher Memorial Lecture - Kin Selection and Altruism. Proc R Soc (Lond) [B] 1983;219:327-353.
33. Dickson RB, Johnson MD, Bano M, Shi E, Kurebayashi J, Ziff B, Martinez-Lacaci I, Amundadottir LT, Lippman ME: Growth factors in breast cancer: Mitogenesis to transformation. J Steroid Biochem Mol Biol 1992;43:69-78.
34. Lippman ME, Dickson RB, Bates S, Knabbe C, Huff K, Swain S, McManaway M, Bronzert D, Kasid A, Gelmann EP: Autocrine and paracrine growth regulation of human breast cancer. Breast Cancer Res Treat 1986;7:59-70.
35. Meager A: Cell proliferation growth factors, and oncogenes; in Cytokines. Englewood Cliffs, Prentice- Hall, 1991, pp 20-64.
36. Gros P, Shustik C: Multidrug resistance: A novel class of membrane- associated transport proteins is identified. Cancer Invest 1991;9:563-569.
37. Cheng KC, Loeb LA: Genomic instability and tumor progression: Mechanistic considerations; in Vande Woude GF, Klein G (eds): Advances in Cancer Research. San Diego, Academic Press, 1993, pp 121-156.
38. Hill RP: Tumor progression: Potential role of unstable genomic changes. Cancer Metast Rev 1990;9:137-147.
39. Knudson AG Jr: Overview: Genes that predispose to cancer. Mutat Res 1991;247:185-190.
40. Nowell PC: Biology of disease - Cancer, chromosomes, and genes. Lab Invest 1992;66:407-417.
41. Volpe JPG: Genetic instability of cancer - Why a metastatic tumor is unstable and a benign tumor is stable. Cancer Genet Cytogenet 1988;34:125-134.
42. Collard JG, Roos E, La Riviere G, Habets GGM: Genetic analysis of invasion and metastasis. Cancer Surv 1988;7:691-710.
43. Folkman J: The role of angiogenesis in tumor growth. Cancer Biol 1992;3:65-71.
44. Bertalanffy LV: Principles and theory of growth; in Nowinski WW (ed): Fundamental Aspects of Normal and Malignant Growth. Amsterdam, Elsevier, 1960, pp 137-259.
45. Burns ER: On the failure of self- inhibition of growth of tumors. Growth 1969;33:25-45.
46. Duchting W, Vogelsaenger T: Modeling and simulation of growing spheroids. Rec Res Cancer Res 1984;95:168-179.
47. Gatenby RA: Population ecology issues in tumor growth. Cancer Res 1991;51:2542-2547.
48. Gateby RA: Population ecology issues in tumor growth (preprint) 1993;1-24.
49. Kendal WS: Gompertzian growth as a consequence of tumor heterogeneity. Mathemat Biosci 1984;73:103- 107.
50. Klein G, Revesz L: Quantitative studies on the multiplication of neoplastic cells in vivo. I. Growth curves of the Ehrlich and MC1M ascites tumors. J Natl Cancer Inst 1953;14:229-277.
51. Laird AK: Dynamics of tumour growth: Comparison of growth rates and extrapolation of growth curve to one cell. Br J Cancer 1965;19:278- 291.
52. Laird AK: Dynamics of growth in tumors and in normal organisms. Nat Cancer Inst Monogr 30. Bethesda, National Cancer Institute, 1969, pp 15-28.
53. Spratt JA, Foruneir Dv, Spratt JS, Weber EE: Decelerating growth and human breast cancer. Cancer 1993;71:2013-2019.
54. Steel GG: Growth Kinetics of tumours - Cell Population Kinetics in Relation to the Growth and Treatment of Cancer. Oxford, Clarendon Press, 1977.
55. Greengard O, Head JF: Common characteristics of normal and cancerous growth in vivo. Adv Enzyme Regul 1992;32:211-224.
56. Michelson S, Leith J: Autocrine and paracrine growth factors in tumor growth: A mathematical model. Bull Mathemat Biol 1991;53:639-656.
57. Kerbel RS: Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Am J Pathol 1992;141:519-524.
58. Aaronson SA: Growth factors and cancer. Science 1991;254:1146- 1153.
59. Sporn MB, Roberts AB: Autocrine growth factors and cancer. Nature 1985;313:745-747.
60. Sugarbaker EV: Cancer metastasis: A product of tumor-host interactions. Curr Probl Cancer 1979;3:3- 59.
61. Stewart CC, Beetham KL: Cytocidal activity and proliferative ability of macrophages infiltrating the EMT6 tumor. Int J Cancer 1978;22:152- 159.
62. Whitworth PW, Pak CC, Esgro J, Kleinerman ES, Fidler IJ: Macrophages and Cancer. Cancer Metast Rev 1990;9:319-351.
63. Apffel CA:Non-immunological host defenses: A review. Cancer Res 1976;36:1527-1537.
64. Kerbel RS: Growth dominance of the metastatic cancer cell: Cellular and molecular aspects. Adv Cancer Res 1990;55:87-132.
65. Waghorne C, Thomas M, Lagarde A, Kerbel RS, Breitman ML: Genetic evidence for progressive selection and overgrowth of primary tumors by metastatic cell subpopulations. Cancer Res 1988;48:6109-6114.
66. Herlyn M: Human melanoma: Development and progression. Cancer Metast Rev 1990;9:101-112.
67. Whittemore A, Keller JB: Qualitative theories of carcinogenesis. SIAM Rev 1978;20:1-30.
68. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ (eds): Manual for Staging of Cancer, Philadelphia, Lippincott, 1992.
69. Greller LD, Tobin FL, Poste G: Computational tumor heterogeneity and progression; in Witten M (ed): Computational Medicine, Public Health and Biotechnology: Building a Man in the Machine, part 1. Singapore, World Scientific Publishing Co., 1995, pp 413-441.
70. Hsu TC: Genetic instability in the human population: A working hypothesis. Hereditas 1983;98:1-9.
71. Nicolson GL: Generation of phenotypic diversity and progression in metastatic tumor cells. Cancer Metast Rev 1984;3:25-42.
72. Nicolson GL: Tumor cell instability, diversification, and progression to the metastatic phenotype: From oncogene to oncofetal expression. Cancer Res 1987;47:1473-1487.
73. Haitl DL, Clark AG: Principles of population genetics, ed 2. Sunderland, Sinauer, 1989.
74. Rosen R: Dynamical System Theory in Biology - vol I: Stability Theory and Its Applications. New York, Wiley-Interscience, 1970.
75. Farber E, Cameron R: The sequential analysis of cancer development; in Vande Woude GF, Klein G (eds): Advances in Cancer Research. San Diego, Academic Press, 1980, pp 125-226.
76. Wolman SR, Borland AA: Genetics of tumor cells; in Becker FF (ed): Cancer - A Comprehensive Treatise, V3, Biology of Tumors. New York, Plenum Press, 1975, pp 155- 198.
77. Heim S, Mandahl N, Mittleman F: Genetic convergence and divergence in tumor progression. Cancer Res 1988;48:5911-5916.
78. Sato T, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y: Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res 1991;51:5794-5799.
79. Sandberg AA: Cytogenetic and molecular genetic aspects of human prostate cancer: Primary and metastatic; in Karr JP, Yamanaka H (eds): Prostate Cancer and Bone Metastasis. New York, Plenum Press, 1992, pp 45-74.
80. Sugimura T: Multistep carcinogenesis: A 1992 perspective. Science 1992;258:603-607.
81. Rubin AL, Yao A, Rubin H: Relation of spontaneous transformation in cell culture to adaptive growth and clonal heterogeneity. Proc Nat Acad Sci USA 1990;87:482-486.
82. Rubin H: The significance of biological heterogeneity. Cancer Metast Rev 1990;9:1-20.
83. Loeb LA: Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 1991;51:3075- 3079.
84. Knudson AG Jr. Stem cell regulation, tissue ontogeny, and oncogenic events. Cancer Biol 1992;3:99-106.
85. Rubin H: Cancer as a dynamic developmental disorder. Cancer Res 1985;45:2935-2942.
86. Moolgavkar SH, Knudson AG Jr: Mutation and cancer: A Model for Human Carcinogenesis. J Nat Cancer Inst 1981;66:1037-1052.
87. Eisen M: Mathematical models in cell biology and cancer chemotherpay; in Levin S (ed): Lecture Notes in Biomathematics. New York, Springer, 1979, vol 30.
88. Tautu P (ed): Stochastic Modelling in Biology. Workshop in Heidelberg, 8-12 Aug. 1988. Singapore, World Scientific, 1990.
89. Wheldon TE: Mathematical Models in Cancer Research. Bristol, Adam Hilger, 1988.
90. Whittemore AS: Quantitative theories of oncogenesis. Adv Cancer Res 1978;27:55-88.
91. Hunter T: Cooperation between oncogenes. Cell 1991;64:249-270.
92. Armitage P, Doll R: Stochastic models for carcinogenesis. 4th Berkeley Symp Mathematical Statistics, 1961, pp 19-38.
93. Murdoch DJ, Krewski DR: Quantitative theories of carcinogenesis; in Thompson JR, Brown BW (eds): Cancer Modelling. New York, Marcel Dekker, 1987, pp 61-89.
94. Hethcote HW, Knudson AG Jr: Model for the incidence of embryonal cancers: Application to retinoblastoma. Proc Natl Acad Sci USA 1978;75:2453-2457.
95. Moolgavkar SH, Venzon DJ: Two- event models for carcinogenesis: Incidence curves for childhood and adult tumors. Mathemat Biosci 1979;47:55-77.
96. Moolgavkar SH: Carcinogenesis modeling: From molecular biology to epidemiology. Ann Rev Publ Hlth 1986;7:151-169.
97. Marx J: Chromosome ends catch fire. Science 1994;265:1656- 1658.
98. Counter CM, Hirte HW, Bacchetti S, Harley CB: Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994;91:2900- 2904.
99. Fearon Er, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990;61:759-767.
100. Sidransky D, Messing E: Molecular genetics and biochemical mechanisms in bladder cancer. Urol Clin N Am 1992;19:629-639.
101. Reid BJ, Blount PL, Rubin CE, Levine DS, Haggitt RC, Rabinovitch PS: Flow-cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohort. Gastroenterology 1992;12:1212-1219.
102. Sidranksy D, Boyle J, Koch W, Riet P: Oncogene mutations as intermediate markers. J Cell Biochem 1993;17F(suppl):184-187.
103. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, Vogelstein B: Identification of chromosome 18q gene that is altered in colorectal cancer. Science 1990;247:49-56.
104. Nei M: The theory and estimation of genetic distance; in Morton NE (ed): Genetic Structure of Populations: Honolulu, University Press of Hawaii, 1973, pp 45-59.
105. Nei M: Mathematical models of speciation and genetic distance; in Karlin S, Nevo E (eds): Population Genetics and Ecology. New York, Academic Press, 1976, pp 723- 765.
106. Fogel DB: Evolutionary computation - Towards a new philosophy of machine intelligence; in Anderson JB (ed): IEEE Press/IEEE Neural Networks Council. New York, IEEE, 1995.
107. Latter BDH: Measures of genetic distance between individuals and populations; in Morton NE (ed): Genetic Structure of Populations. Honolulu, University Press of Hawaii, 1973, pp 27-39.
108. Smith JM: Natural selection and the concept of a protein space. Nature 1970;225:563-564.
109. Kauffman SA: Adaptation on rugged fitness landscapes; in Stein DL (ed): Lectures in the Sciences of Complexity, Lectures vol I. Redwood City, Addison-Wesley, 1989, pp 527-618.
110. Sellers PH: On the theory and computation of evolutionary distances. SIAM J Appl Mathemat 1974;26:787-793.
111. Eigen M, Winkler-Oswatitsch R, Dress A: Statistical geometry in sequence space: a method of quantitative comparative sequence analysis. Proc Natl Acad Sci USA 1988;85:5913-5917.
112. Eigen M, Winkler-Oswatitsch R: Statistical geometry on sequence space. Meth Enzymol 1990;183:505-530.
113. Schuster P: RNA based evolutionary optimization. Origins Life Evolution Biosphere 1993;23:373-391.
114. Vingron M, Sibbald PR: Weighting in sequence space: A comparison method in terms of generalized sequences. Proc Natl Acad Sci USA 1993;90:8777-8781.
115. Varmus H, Weinberg RA: Genes and the Biology of Cancer. New York, Scientific American Library, Division of HPHLP, 1993.
116. Wolman SR: Cytogenetic heterogeneity: Its role in tumor evolution. Cancer Genet Cytogenet 1986;19:129-140.
117. Berstam VA: Handbook of Gene Level Diagnostics in Clinical Practice. Boca Raton, CRC Press, 1992.
118. Pedersen B: Clonal evolution and progression in chronic myeloid Leukemia; in Bessis M, Brecher G (eds); Unclassifiable Leukemias. New York, Springer, 1975, pp 227-234.
119. Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P, Vogelstein B: Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992;256:102-105.
120. Fearon ER: Genetic alterations underlying colorectal tumorigenesis. Cancer Surv 1992;12:119-136.
121. Poste G, Doll J, Fidler U: Interactions among clonal subpopulations affect the stability of metastatic phenotype in polyclonal populations of B16 melanoma cells. Proc Natl Acad Sci USA 1981;78:6226- 6230.
122. Miller FR: Tumor subpopulation interactions in metastasis. Invasion Metast 1983;3:234-242.
123. Miller FR, Heppner GH: Cellular interactions in metastasis. Cancer Metast Rev 1990;9:21-43.
124. Sutherland RM: Cell and environment interactions in tumor microregions: The multicellular spheroid model. Science 1988;240:177-184.
125. Moore M: Tumor resistance and the phenomenon of inflammatory- cell infiltration; in Fox BW, Fox M (eds): Antitumor Drug Resistance. Berlin, Springer, 1980, pp 403- 424.
126. Sulitzeanu D: Immunosuppressive factors in human cancer. Adv Cancer Res 1993;60:247-267.
127. Nowak MA, May RM, Anderson RM: The evolutionary dynamics of HIV-1 quasispecies and the development of immunodeficiency disease. AIDS 1990;11:1095- 1103.
128. Greller LD, Poste G, Tobin FL, Wang X: Genetic instability and progression interactions in tumor dynamics. Int Workshop on Information Processing in Cells and Tissues (IPCAT95), Liverpool, 1995.
129. Rubinow SI: Mathematical problems in the biological sciences. Conference Board of the Mathematical Sciences. Philadelphia, Society for Industrial and Applied Mathematics, 1973, vol 10.
130. Hartmann NR, Moller U, Lebeda J: Analysis of cell kinetic data on the basis of mathematical models; in Drewinko B, Humphrey RM (eds): Growth Kinetics and Biochemical Regulation of Normal and Malignant Cells. Baltimore, Williams & Wilkins, 1977, pp 471-480.
131. Hartmann NR, Moller U: A compartment theory in the cell kinetics including considerations of circadian variations; in Valleron A-J, Macdonald FDM (eds): Biomathematics and Cell Kinetics. Amsterdam, Elsevier/North-Holland, 1978, pp 223-251.
132. Jackson RC: The Theoretical Foundations of Cancer Chemotherapy by Computer Models. San Diego, Academic Press, 1992.
133. Drewinko B, Humphrey RM (eds): Growth Kinetics and Biochemical Regulation of Normal and Malignant Cells. Baltimore, Williams & Wilkins, 1977.
134. Valleron A-J, Macdonald PDM (eds): Biomathematics and Cell Kinetics. Amsterdam, Elsevier/ North-Holand, 1978, vol 2.
135. Lloyd HH: Application of tumor models toward the design of treatment schedules for cancer chemotherapy; in Drewinko B, Humphrey RM (eds): Growth Kinetics and Biochemical Regulation of Normal and Malignant Cells. Baltimore, Williams & Wilkins, 1977, pp 455-469.
136. Yamamoto WS: A succession of improbable models: in Yamamoto WS, Brobeck JR (eds): Physiological Controls and Regulations. Philadelphia, Saunders, 1965, chap 3, pp 32-53.
137. Vaughan DP: Systems analysis in Pharmacokinetics; in Taylor JB (ed): Comprehensive Medical Chemistry. Oxford, Pergamon Press, 1990, sec 24.6, pp 503-544.
138. Mazumdar J: An introduction to mathematical physiology and biology; in Morris SA (ed): Australian Mathematical Society Lecture Series. Cambridge, Cambridge University Press, 1989, vol 4.
139. Gaillot J, Bruno R, Montay G: Distribution and clearance concepts; in Taylor JB (ed): Comprehensive Medicinal Chemistry. Oxford, Pergamon Press, sec 23.3, pp 71-110.
140. Houk JC: Systems and models; in Mountcastle VB (ed): Medical Physiology. St. Louis, Mosby, 1980, pp 227-245.
141. Rubinow SI: A maturity-time representation for cell populations. Biophys J 1968;8:1055-1073.
142. Murray JD: Mathematical biology, in Levin SA (ed): Biomathematics Texts. New York, Springer 1989, vol 19.
143. Aroesty J, Lincoln T, Morrison P, Carter G: Cell kinetic models of transient states: A preliminary investigation of lymphocyte stimulation; in Drewinko B, Humphrey RM (eds); Growth Kinetics and Biochemical Regulation of Normal and Malignant Cells. Baltimore, Williams & Wilkins, 1977, pp 435-453.
144. Lebowitz JL, Rubinow SI: A theory for the age and generation time distribution of a microbial population. J Mathemat Biol 1974;1:17- 36.
145. Bannasch P: Phenotypic cellular changes as indicators of stages during neoplastic development; in Iversen OH (ed): Theories of Carcinogenesis. Cambridge, Hemisphere, 1988, pp 231-247, chap 19.
146. Hainsworth JD, Greco FA: Treatment of patients with cancer of unknown primary site; in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Important Advances in Oncology 1991. Philadelphia, Lippincott, 1991, pp 173-190.
147. Dunphy JE: Some observations of the natural behavior of cancer in man. N Engl J Med 1950;242:167- 172.
148. Derynck R: The physiology of transforming growth factor-alpha; in Vande Woude GF, Klein G (eds): Advances in Cancer Research. San Diego, Academic Press, 1992, pp 27-52.
149. Levine AJ: Viruses. New York, Scientific American Library, Division of HPHLP, 1992.
150. Sugarbaker EV, Thornthwaite J, Ketcham AS: Inhibitory effect of a primary tumor on metastasis; in Day SB, Myers WPL, Stansly P, Garattini S, Lewis MG (eds): Cancer Invasion and Metastasis: Biologic Mechanisms and Therapy. New York, Raven Press, 1977, pp 227-240.
151. Jones PA, Droller MJ: Pathways of development and progression in bladder cancer: New correlations between clinical observations and molecular mechanisms. Semin Urol 1993;11:177-190.
152. Simoneau AR, Jones PA: Bladder cancer: The molecular progression to invasive disease. World J Urol 1994;12:89-95.
153. Sandberg AA, Berger CS: Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer. J Urol 1994;151:545-560.
154. Kerbel RS, Waghorne G, Korczak B, Lagarde A, Breitman ML: Clonal dominance of primary tumors by metastatic cells: Genetic analysis and biological implications. Cancer Surv 1988;7:598-629.
155. Ling V, Chambers AF, Harris JF, Hill RP: Dynamic heterogeneity and metastasis. J Cell Physiol 1984;3(suppl):99-103.
156. Owens AH, Coffey DS, Baylin SB: Tumor Cell Heterogeneity: Origins and Implications. New York, Academic Press, 1982.
157. Poste G: Tumor cell heterogeneity and the pathogenesis of cancer metastasis; in Torisu M, Yoshida T (eds): Basic Mechanisms and Clinical Treatment of Tumor Metastasis: Orlando, Academic Press, 1985, pp 80-100.
158. Inouye K: Control mechanism of stalk formation in the cellular slime mold Dictyostelium discoideum. FORMA 1990;5:119-134.
159. Gierer A, Meinhardt H: A theory of biological pattern formation. Kybemik 1972;12:30-39.
160. Murray JD: How the leopard gets its spots. Sci Am 1988;258:80-87.
161. Swinney HL, Krinsky VI (eds): Waves and Patterns in Chemical Media. Cambridge, MIT Press/ North-Holland, 1992.
162. Gierer A, Meinhardt H: Biological pattern formation involving lateral inhibition; in Levin SA (ed): Some Mathematical Questions in biology - VI. Providence, American Mathematical Society, 1974, pp 163-184.
163. Michelson S, Leith JT: Growth factors and growth control of heterogeneous cell populations. Bull Mathemat Biol 1993;55:993- 1011.
164. Greig R, Dunnington D, Murthy U, Anzano M: Growth factors as novel therapeutic targets in neoplastic disease. Cancer Surv 1988;7:653-674.
165. Roberts AB, Sporn MB: The transforming growth factor-betas; in Sporn MB, Roberts AB (eds): Peptide Growth Factors and Their Receptors. New York, Springer 1990, pp 419-472.
166. Nicolson GL: Gene expression, cellular diversification and tumor progression to the metastatic phenotype. BioEssays 1991;13:204- 208.
167. Wolman SR, Camuto PM, Perle MA: Cytogenetic diversity in primary human tumors. J Cell Biochem 1988;36:147-156.
168. Nowell PB, Balaban G: Karyotypic progression and metastasis formation of human tumors; in Lapis K, Liotta LA, Rabson AS (eds): Biochemistry and Molecular Genetics of Cancer Metastasis. Boston, Martinus Nijhoff Publishing, 1986, pp 129-136.
169. Bronner CE, Maker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford J, Lindblom A, Tannergard P, Bollag RJ, Godwin AR, Ward DC, Mordenskjold M, Fishel R, Kolodner R, Liskay RM: Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994;368:258- 261.
170. Papadopoulos N, Nicolaides NC, Wei Y-F, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Hamilton SR, Petersen GM, Watson P, Lynch HT, Peltomäki P, Mecklin J-P, Chapelle Adl, Kinder KW, Vogelstein B: Mutation of a mutL homolog in hereditary colon cancer. Science 1994;263:1625-1628.
171. Palombo F, Hughes M, Jiricny J, Truong O, Hsuan J: Mismatch repair and cancer. Nature 1994;367:417.
172. Kuhl DPA, Caskey CT: Trinucleotide repeats and genome variation. Curr Opin Genet Dev 1993;3:404- 407.
173. Strand M, Prolla TA, Liskay RM, Petes TD: Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature 1993;365:274-476.
174. Marx J: Tumor biology - Cellular changes on the route to metastasis. Science 1993;259:626-629.
175. Feldman M, Eisenbach L: Genes controlling the metastatic phenotype. Cancer Surv 1988;7:555- 572.
176. Field JA, Spandidos DA: The role of ras and myc oncogenes in human solid tumours and their relevance in diagnosis and prognosis (review). Anticancer Res 1990;10:1-22.
177. Waghorne C, Breitman ML, Kerbel RS: Application of gene transfer to the study of tumor progression and metastasis. Tumor Progression Metastasis 1988;135- 151.
178. McLaughlin PJ, Dayhoff MO: Evolution of species and proteins: A time scale; in Dayhoff MO (ed): Atlas of Protein Sequence and Structure 1972. Washington, National Biomédical Research Foundation, 1972, pp 47-52.
179. Kishino H, Hasegawa M: Converting distance to time: Application to human evolution; in Doolittle RF (ed): Molecular Evolution: Computer Analysis of Protein and Nucleic Acid Sequences. San Diego, Academic Press, 1990, pp 550- 570.
180. Saccone C, Lanave C, Pesole G, Preparata G: Influence of base composition on quantitative estimates of gene evolution; in Doolittle RF (ed): Molecular Evolution: Computer Analysis of Protein and Nucleic Acid Sequences. San Diego, Academic Press, 1990, pp 570- 736.
181. Tavare S: Calibrating the clock: Using stochastic processes to measure the rate of evolution; in Lander ES, Waterman MS (eds): Calculating the Secrets of Life. Washington, National Academy Press, 1995, pp 114-152.
182. Puck TT, Krystosek A: Reverse transformation, genome exposure, and cancer; in Vande Woude GF, Klein G (eds): Advances in Cancer Research. San Diego, Academic Press, 1993, pp 125-151.
183. Young CW, Warrell RP: Differentiating agents; in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer - Priniciples and Practice of Oncology. Philadelphia, Lippincott, 1993, pp 2636-2646.
184. Waddington CH: Principles of Development and Differentiation; in Giles NH, Kenworthy W, Torrey JG (eds): Current Concepts in Biology Series. New York, Macmillan, 1966.
185. Wolpert L: The Triumph of the Embryo. New York, Oxford University Press, 1991.
186. Sachs L: Cell differentiation and bypassing of genetic defects in suppression of malignancy. Cancer Res 1987;47:1981-1986.
187. Marchuk GI, Asachenkov AL, Smolyaninov Y, Sobolev BG: On the problem of processing clinical and laboratory data on oncological patients. Soviet J Numer Anal Mathemat Modelling 1989;4:381- 396.
188. Asachenkov A, Marchuk G, Mohler R, Zuev S: Disease dynamics; in Byrnes CI, et al (eds): Systems and Control: Foundations and Applications. Boston, Birkhäuser and The International Institute for Applied Systems Analysis, 1994.
189. Goldie J, Coldman A: A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 1979;63:1727-1733.
190. Goldie JH: Drug resistance and chemotherapeutic strategy; in Owens AH, Coffey DS, Baylin SB (eds): Tumor Cell Heterogeneity: Origins and Implications New York, Academic Press, 1982, pp 115-125.
191. Coldman A, Goldie J: A model for the resistance of tumor cells to cancer chemotherapeutic agents. Mathemat Biosci 1983;65:291-307.
192. Goldie JH: Resistance and cancer chemotherapy: General principals; in Hellman KB, Carter SK (eds): Fundamentals of Cancer Chemotherapy. New York, McGraw-Hill, 1987, pp 41-47.
193. Coldman AJ, Goldie JH: Modeling resistance to cancer chemotherapeutic agents; in Thompson JR, Brown BW (eds): Cancer Modelling. New York, Marcel Dekker, 1987, pp 315-364.
194. Goldie JH, Coldman AJ: Mathematical modelling of drug resistance; in Woolley PV III, Tew KD (eds): Mechanism of Drug Resistance in Neoplastic Cells. San Diego, Academic Press, 1988, pp 13- 28.
195. Day RS: Treatment sequencing, asymmetry, and uncertainty: Protocol strategies for combination chemotherapy. Cancer Res 1986;46:3876-3885.
196. Norton L, Day R: Potential innovations in scheduling of cancer chemotherapy; in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Important Advances in Oncology 1991. Philadelphia, Lippincott, 1991, pp 57-72.